Monarch Capital Management Inc. Increases Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Monarch Capital Management Inc. grew its position in shares of ZimVie Inc. (NASDAQ:ZIMV) by 6.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,700 shares of the company’s stock after purchasing an additional 4,140 shares during the period. Monarch Capital Management Inc.’s holdings in ZimVie were worth $753,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Principal Financial Group Inc. grew its position in shares of ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock worth $266,000 after buying an additional 1,702 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of ZimVie by 0.9% in the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock worth $1,404,000 after buying an additional 943 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of ZimVie by 18.7% during the 4th quarter. JPMorgan Chase & Co. now owns 217,773 shares of the company’s stock valued at $3,038,000 after buying an additional 34,354 shares during the last quarter. LPL Financial LLC acquired a new stake in ZimVie during the fourth quarter worth about $993,000. Finally, BNP Paribas Financial Markets bought a new position in ZimVie in the fourth quarter worth about $416,000. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Stock Up 1.7%

ZimVie stock opened at $9.55 on Wednesday. ZimVie Inc. has a twelve month low of $8.15 and a twelve month high of $22.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The firm has a market cap of $265.94 million, a PE ratio of -0.73 and a beta of 2.10. The firm’s 50 day moving average price is $9.09 and its two-hundred day moving average price is $11.88.

ZimVie (NASDAQ:ZIMV) last posted its earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.06. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The firm had revenue of $112.00 million during the quarter, compared to analyst estimates of $113.10 million. On average, research analysts predict that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently commented on ZIMV. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research note on Wednesday, April 9th. UBS Group cut their price target on ZimVie from $16.00 to $10.00 and set a “neutral” rating on the stock in a report on Thursday, May 15th. Finally, B. Riley started coverage on ZimVie in a research report on Thursday, April 10th. They set a “buy” rating and a $16.00 price target for the company.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.